MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
14.90
-0.10 (-0.67%)
At close: Dec 5, 2025, 4:00 PM EST
15.00
+0.10 (0.67%)
After-hours: Dec 5, 2025, 7:59 PM EST

MLTX Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for MLTX stock ranges from a low of $5.00 to a high of $85. The average analyst price target of $36.33 forecasts a 143.83% increase in the stock price over the next year.

Price Target: $36.33 (+143.83%)
Analyst Consensus: Buy
Target Low Average Median High
Price $5.00 $36.33 $20 $85
Change -66.44% +143.83% +34.23% +470.47%

Analyst Ratings

The average analyst rating for MLTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '25Jul '25Aug '25Sep '25Oct '25Nov '25
Strong Buy 333434
Buy 554222
Hold 000332
Sell 000000
Strong Sell 000011
Total 887999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$30$26
Strong Buy Maintains $30$26 +74.50% Nov 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$30
Strong Buy Upgrades $30 +101.34% Nov 3, 2025
Citigroup
Citigroup
Strong Sell
Downgrades
$5
Strong Sell Downgrades $5 -66.44% Oct 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Oct 2, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$80$20
Strong Buy Maintains $80$20 +34.23% Sep 30, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.63
from -1.89
EPS Next Year
-3.63
from -3.63
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
------54.33M
Revenue Growth
-------
EPS
-8.21-1.70-0.73-1.89-3.63-3.63-3.49
EPS Growth
-------
Forward PE
-------
No. Analysts
----191813
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -3.49 -2.66
Avg -3.63 -3.63
Low -3.62 -4.25

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.